We have postulated that SLC2A3 might regulate the progression of GC by promoting glycolysis reprogramming, activating the STAT3 signaling pathway, and increasing tumor microenvironment macrophage infiltration and M2 subtype transition (Fig. 6c). This evidence concerns the gene SLC2A3 and gastric cancer.